Clinical Trials Browser

Terminated × Breast Neoplasms × Sorafenib × Clear all

NCT03878524 2024-03-04

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Phase 1 Terminated

BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT00622466 2020-10-19

Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer

Phase 2 Terminated

20 enrolled 8 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT02624700 2020-07-14

2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer

Phase 2 Terminated

13 enrolled 13 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00722072 2018-02-26

Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy

Phase 2 Terminated

12 enrolled 7 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00632541 2018-02-14

A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer

Phase 2 Terminated

18 enrolled 11 charts

Breast Neoplasms

NCT01194869 2016-10-18

Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer

Phase 2 Terminated

25 enrolled 8 charts

Breast Neoplasms

NCT00525161 2015-01-26

Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer

Phase 2 Terminated

11 enrolled 20 charts

Breast Neoplasms

NCT00964743 2013-09-09

Depocyt® With Sorafenib in Neoplastic Meningitis

Phase NA Terminated

2 enrolled 6 charts

Breast Neoplasms, Neurologic Manifestations, Meningeal Carcinomatosis

NCT00607438 2012-05-11

A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer

Phase 2 Terminated

Breast Neoplasms, Neoplasm Metastasis